There is no other screening program close to the success rate of PAP test. Cervical cytology constitutes a large workload so that quality control in cervical cytology is important for the quality assurance of pathology laboratories. In this study, we collected the cervical cytology results from all over Turkey and discussed the parameters influencing the quality of the PAP test. The study was conducted with Turkish gynaecopathology working group and 38 centers (totally 45 hospitals) agreed to contribute from 24 different cities. The study was designed to cover the cervical cytology results during 2013. The results were evaluated from the data based on an online questionnaire. The total number of Epithelial Cell Abnormality was 18,020 and the global Epithelial Cell Abnormality rate was 5.08% in the total 354,725 smears and ranging between 0.3% to 16.64% among centers. The Atypical squamous cells /Squamous intraepithelial lesion ratios changed within the range of 0.21-13.94 with an average of 2.61. When the centers were asked whether they performed quality assurance studies, only 14 out of 28 centers, which shared the information, had such a control study and some quality parameters were better in these centers. There is an increase in the global Epithelial Cell Abnormality rate and there are great differences among centers. Quality control studies including the Atypical squamous cells/Squamous intraepithelial lesion ratio are important. Corrective and preventive action according to quality control parameters is a must. A cervical cytology subspecialist in every center can be utopic but a dedicated pathologist in the center is certainly needed.
Amaç: Alport sendromu hematüri, ilerleyici böbrek yetmezliği, işitme kaybı ve oküler anormalliklerle seyreden bir hastalıktır. Bu çalışmada merkezimizde Alport sendromu tanısıyla izlenen hastaların demografik, klinik ve laboratuvar bulguları ile renal biyopsilerinin histopatolojik ve elektron mikroskobik bulgularının değerlendirilmesi amaçlanmıştır. Yöntem: Çocuk Nefroloji Kliniğinde Haziran 2004 ile Ocak 2018 tarihleri arasında takip edilen 14 Alport sendromlu hastanın başvuru şikayetleri, aile hikayesi, renal tutulumu, göz ve işitme bulguları, böbrek biyopsilerinin histopatolojik ve elektron mikroskobik değerlendirmeleri geriye dönük olarak incelendi. Bulgular: Yedisi kız ve yedisi erkek olmak üzere toplam 14 hasta değerlendirildi. Hastaların yaşları 15 ay-17 yıl arasındaydı (ortalama 10.7±3.8 yıl). On bir hasta hematüri, bir hasta vücutta şişlik, iki hasta ise şikâyeti olmaksızın ailelerinde Alport sendromu öyküsü olması nedeniyle araştırılmak üzere başvurdu. Anne-baba arasında akrabalık beş hastada bulunurken, 11 hastanın ailesinde Alport sendromu öyküsü mevcuttu. Sensorinöral işitme kaybı yedi hastada saptandı. Bilateral anterior lentikonus son dönem böbrek yetmezliği kliniğinde başvuran bir hastada saptandı. Böbrek biyopsisi yapılan 10 hastanın elektron mikroskobik incelenmesinde, tüm vakalarda glomerül bazal membranında incelmeler, kalınlaşmalar ve sepet görünümü ile karakterize düzensizlikler gösterildi. Sonuç: Hematüri şikayetiyle başvuran hastalarda aile öyküsünün sorgulanması, göz muayenesi ve işitme testlerinin yapılması Alport sendromu tanısını koymada yol gösterici olmaktadır. Elektron mikroskobide glomerul bazal membrandaki tipik değişikliklerin görülmesi tanıyı kesinleştirmektedir.
Complement-mediated thrombotic microangiopathy (cmTMA), historically referred to as atypical hemolytic uremic syndrome, is driven by dysregulated alternative complement activation and is often unmasked by secondary triggers. A 40-year-old man with pre-existing hypertension (peak blood pressure: 145/94 mmHg) who presented with microangiopathic hemolytic anemia, severe thrombocytopenia, and acute kidney injury requiring hemodialysis is reported. Therapeutic plasma exchange was initiated while thrombotic thrombocytopenic purpura was being excluded, and eculizumab was started after meningococcal vaccination and antibiotic prophylaxis (900 mg weekly induction followed by biweekly maintenance). During the workup for recurrent hematochezia, a transverse colon adenocarcinoma was diagnosed and resected, without the need for adjuvant chemotherapy. Hematologic remission was achieved on eculizumab, and renal function partially recovered, allowing discontinuation of dialysis at 3 months. However, chronic kidney disease (CKD) persisted at the last follow-up (creatinine 2.17 mg/dL; estimated glomerular filtration rate(eGFR) 38 mL/min/1.73 m2; CKD stage 3b). Genetic analysis identified a homozygous CFH splice-site variant (c.1159+4A>C), supporting underlying complement dysregulation. This case highlights the importance of prioritizing genetic evaluation and modern nomenclature in cmTMA occurring in the context of malignancy. Cite this article as: Gür MB, Özcan SG, Dinçer MT, et al. A novel homozygous CFH variant associated with atypical hemolytic uremic syndrome triggered by colorectal cancer: A case report. Cerrahpaşa Med J. 2026, 50, 0103, doi: 10.5152/cjm.2026.25103.
21 March 2022 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Our study aimed to determine immunohistochemical expression of ER, PR, C-erbB-2, p53 and BRCA1 genes and their relationship with clinicopathological features and prognostic significance. The present study included 85 patients that were diagnosed with epithelial OC, treated and followed-up between 2002 and 2012 at Mersin University, Faculty of Medicine. Immunohistochemical expression of ER, PR, C-erbB-2, p53 and BRCA1 and their relation-ship with clinicopathological parameters were evaluated. In serous carcinomas, expression of ER was significantly associated with metastasis to the fallopian tube, expression of PR was significantly associated with patient’s age, expression of p53 was significantly associated with the progression-free survival (PFS), cytoplasmic expression of BRCA1 was significantly associated with the overall survival (OS) and PFS. In pathogenesis groups, 55 tumors were type 1, and 30 tumors were type 2. There were significant correlations with ER, PR and p53 expressions between the two groups. In our study, PR and p53 were prognostic factors in serous carcinoma. Extensive studies that contain more cases in each histological group are needed to determine the prognostic value of these five immunohistochemical markers.
21 October 2026 in International Journal of Urology